Evidence map›Paper›PMID 35317089›Full record

ArticleJournal of medical cases2022

Severe Gastroparesis Flare: Is COVID-19 the Inciting Factor?

Aditya Patel, Ruhma Ali, Muhammad Hussain, Jihad Slim, Theodore DaCosta

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aditya PatelDepartment of Internal Medicine, Saint Michael's Medical Center, Newark, NJ, USA.
Ruhma AliDepartment of Internal Medicine, Saint Michael's Medical Center, Newark, NJ, USA.
Muhammad HussainDepartment of Infectious Disease, Saint Michael's Medical Center, Newark, NJ, USA.
Jihad SlimDepartment of Infectious Disease, Saint Michael's Medical Center, Newark, NJ, USA.
Theodore DaCostaDepartment of Gastroenterology, Saint Michael's Medical Center, Newark, NJ, USA.
Saint Michael's Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has emerged as a public health hazard. It is commonly associated with respiratory symptoms including fever, cough and sore throat. Viral infections have historically been implicated in the exacerbations of gastrointestinal (GI) disorders. Coronavirus disease 2019 (COVID-19) has been associated with GI manifestations including diarrhea and vomiting. However, exacerbation of underlying functional GI disorders has been rarely reported with SARS-CoV-2 infection. Herein we report a case of a 31-year-old female with acute gastroparesis flare secondary to COVID-19 which was refractory to pharmacological therapy.

Indexed as

COVID-19Diabetic gastroparesisFunctional gastrointestinal disordersMetoclopramide

Identifiers

PMID35317089
PMCPMC8913001
OpenAlexW4213195571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.